Top Key Companies for Personalized Healthcare Market: GE Healthcare, Exact Sciences, Decode Genetics, Illumina, Asuragen, Abbott, Dako A/S, Danaher, Qiagen, Exagen.
Global Personalized Healthcare Market Size was estimated at USD 139.38 million in 2022 and is projected to reach USD 167.69 million by 2028, exhibiting a CAGR of 3.13% during the forecast period.
Global Personalized Healthcare Market Overview And Scope:
The Global Personalized Healthcare Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Personalized Healthcare utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Personalized Healthcare Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Personalized Healthcare portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Personalized Healthcare market.
Global Personalized Healthcare Market Segmentation
By Type, Personalized Healthcare market has been segmented into:
Personalized Medicine Therapeutics
Personalized Medicine Diagnostics
By Application, Personalized Healthcare market has been segmented into:
Hospital
Clinic
Regional Analysis of Personalized Healthcare Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Personalized Healthcare Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Personalized Healthcare market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Personalized Healthcare market.
Top Key Companies Covered in Personalized Healthcare market are:
GE Healthcare
Exact Sciences
Decode Genetics
Illumina
Asuragen
Abbott
Dako A/S
Danaher
Qiagen
Exagen
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Personalized Healthcare Market by Type
5.1 Personalized Healthcare Market Overview Snapshot and Growth Engine
5.2 Personalized Healthcare Market Overview
5.3 Personalized Medicine Therapeutics
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Personalized Medicine Therapeutics: Geographic Segmentation
5.4 Personalized Medicine Diagnostics
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Personalized Medicine Diagnostics: Geographic Segmentation
Chapter 6: Personalized Healthcare Market by Application
6.1 Personalized Healthcare Market Overview Snapshot and Growth Engine
6.2 Personalized Healthcare Market Overview
6.3 Hospital
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital: Geographic Segmentation
6.4 Clinic
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Clinic: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Personalized Healthcare Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Personalized Healthcare Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Personalized Healthcare Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 GE HEALTHCARE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 EXACT SCIENCES
7.4 DECODE GENETICS
7.5 ILLUMINA
7.6 ASURAGEN
7.7 ABBOTT
7.8 DAKO A/S
7.9 DANAHER
7.10 QIAGEN
7.11 EXAGEN
Chapter 8: Global Personalized Healthcare Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Personalized Medicine Therapeutics
8.2.2 Personalized Medicine Diagnostics
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospital
8.3.2 Clinic
Chapter 9: North America Personalized Healthcare Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Personalized Medicine Therapeutics
9.4.2 Personalized Medicine Diagnostics
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospital
9.5.2 Clinic
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Personalized Healthcare Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Personalized Medicine Therapeutics
10.4.2 Personalized Medicine Diagnostics
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospital
10.5.2 Clinic
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Personalized Healthcare Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Personalized Medicine Therapeutics
11.4.2 Personalized Medicine Diagnostics
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospital
11.5.2 Clinic
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Personalized Healthcare Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Personalized Medicine Therapeutics
12.4.2 Personalized Medicine Diagnostics
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospital
12.5.2 Clinic
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Personalized Healthcare Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Personalized Medicine Therapeutics
13.4.2 Personalized Medicine Diagnostics
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospital
13.5.2 Clinic
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Personalized Healthcare Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Personalized Medicine Therapeutics
14.4.2 Personalized Medicine Diagnostics
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospital
14.5.2 Clinic
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Personalized Healthcare Scope:
|
Report Data
|
Personalized Healthcare Market
|
|
Personalized Healthcare Market Size in 2025
|
USD XX million
|
|
Personalized Healthcare CAGR 2025 - 2032
|
XX%
|
|
Personalized Healthcare Base Year
|
2024
|
|
Personalized Healthcare Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
GE Healthcare, Exact Sciences, Decode Genetics, Illumina, Asuragen, Abbott, Dako A/S, Danaher, Qiagen, Exagen.
|
|
Key Segments
|
By Type
Personalized Medicine Therapeutics
Personalized Medicine Diagnostics
By Applications
Hospital
Clinic
|
